Autolus Therapeutics announces publication in Nature Communications

LONDON, Feb. 22, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces a publication in Nature...

Related Keywords

London ,City Of ,United Kingdom ,Lauren Williams ,Julia Wilson ,Susana Noonan ,Olivia Manser ,Ferrari ,Nature Communications ,Exchange Commission On ,Exchange Commission ,Sa Noonan Communications ,Nasdaq ,Structure Guided Engineering ,Autolus Therapeutics ,Private Securities Litigation Reform Act ,Autolu Annual Report ,Autolu Quarterly Report ,Markets ,